Nanotechnology Characterization Tools for Biosensing and Medical Diagnosis

Dr. Challa S.S.R. Kumar is currently with Harvard University as a Managing Director. He was previously the Director of Nanofabrication and Nanomaterials at the Center for Advanced Microstructures and Devices at Louisiana State University in Baton Rouge, USA. He is also President and CEO of Magnano Technologies and has some years of industrial R&D experience working for Imperial Chemical Industries and United Breweries. His main research interests are the development of novel synthetic methods, including those based on microfluidic reactors, for the synthesis of multifunctional nanomaterials. Dr. Kumar is the winner of the 2006 Nano 50 Technology Award for his work in magnetic-based nanoparticles for cancer imaging and treatment. He is currently the Editor-in-Chief of the international journal “Nanotechnology Reviews”. He has been editor and author of several books and journal articles, and the founding editor of the Journal of Biomedical Nanotechnology.

• Surface Enhanced Raman Spectroscopy for Medical Diagnostics.- In Vivo Near-Infrared Fluorescence Imaging.- Real-Time Molecular MRI with Hyperpolarized Silicon Particles.- ATR-FTIR Spectroscopy Tools for Medical Diagnosis and Disease Investigation.- Plasmofluidics for Biosensing and Medical Diagnostics.- Upconversion Nanomaterials for Biodetection and Multimodal Bioimaging Using Photoluminescence.- Label-Free Raman Imaging.- MRI and Ultrasound Imaging of Nanoparticles for Medical Diagnosis.- Magnetic Tools for Medical Diagnosis.- Surface Plasmon Resonance Sensors for Medical Diagnosis.- Photoacoustic Imaging Tools for Nanomedicine.- Dendrimer-Based Nanoplatforms for SPECT Imaging Applications.- In Vivo Near-Infrared Fluorescence Imaging Based On Polymer Dot.